Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
Malignant gliomas are the most common primary brain tumors. Their deadliest manifestation, glioblastoma multiforme (GBM), accounts for 15% of all primary brain tumors and is associated with a median survival of only 15 months even after multimodal therapy. There is substantial presence of microglia...
Main Authors: | Anna Carolina Carvalho da Fonseca, Behnam Badie |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/264124 |
Similar Items
-
Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
by: Ian Zhang, et al.
Published: (2016-01-01) -
The Controversial Role of Microglia in Malignant Gliomas
by: Jun Wei, et al.
Published: (2013-01-01) -
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
by: Hongxiang Wang, et al.
Published: (2015-03-01) -
Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
by: Rikke Sick Andersen, et al.
Published: (2021-08-01) -
Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.
by: Konrad Gabrusiewicz, et al.
Published: (2011-01-01)